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Objective
ECMO is a well-established therapy for the 
patients with cardiogenic shock.  
We present a patient who developed severe 
complications while on ECMO. 
Case presentation-1
A 49 year old female presented with severe 
heart failure and was placed on V-A ECMO 
for bridge to decision.
While on ECMO, the patient developed 
massive hemoptysis after Swan-Ganz 
catheter manipulation.  After the 
endotracheal tube was clamped and the 
patient relied on full ECMO support for 36 
hours, the hemoptysis resolved.
Conclusions
ET tube unclamped 36 h after hemoptysis 
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Among the many possible hematologic 
complications, hemoptysis is often difficult to 
control.  In our patient, the hemoptysis was not 
controllable by conventional treatment, thus the 
endotracheal tube was clamped to allow the 
entire airway to tamponade using the advantage 
of ECMO.
Liver function is most important risk factors to 
determine patient survival.  The MARS is a cell-
free extracorporeal liver support device which 
eliminates albumin-bound substances, such as 
bilirubin.  Using MARS, the patient recovered 
liver function to allow to perform LVAD 
placement safely.
While these mechanical circulatory support, 
control of sepsis isolating the source of infection 
was essential for patient survival.
Massive hemoptysis & ET tube clamped
Total bilirubin improved after MARS
.
To our knowledge, this is the first report of a 
patient on ECMO complicated by massive 
hemoptysis and severe acute hepatic failure 
successfully managed and bridged to LVAD.  
Patients can be successfully transitioned from 
ECMO to VAD despite major complications if 
these complications are successfully treated.
Discussion
Case presentation-2
The patient also developed liver failure with 
peak total bilirubin of 56 mg/dl.  The molecular 
adsorbents recirculating system (MARS) device 
was performed from ECMO day 9 to ECMO day 
14.  Liver function improved and the value of 
total bilirubin decreased to 9.9 mg/dl on ECMO 
day 19.
On ECMO day 20, the patient underwent a 
Heart Mate II LVAD placement and successful 
ECMO wean.
During the course of surgical recovery, the 
patient had two episodes of sepsis and VAD 
pocket infection, which was finally controlled 
with antibiotic beads placement into the pocket.
The patient was transferred to an acute 
rehabilitation facility on ECMO day 77.
ECMO
MARS
